USA's Rx Response raised to "Alert Status"

29 April 2009

Rx Response, a partnership created after the 2005 Hurricane Katrina by drugmakers and health care groups to help ensure the continued flow of  medicines to patients in the event of a severe public health emergency,  has been put on Alert Status as concerns grow over the health threat  posed by outbreaks of swine flu in the USA. Billy Tauzin, president and  chief executive of the Pharmaceutical Research and Manufacturers of  America (PhRMA), one of the Rx Response's founding members, said:  "Americans need to know that the medicines they rely on will be  available even in an emergency. Rx Response provides federal and state  crisis managers with the critical information they need about the  pharmaceutical supply chain to help communities affected by an emergency  return to normal as quickly as possible."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight